|
RPP40 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.180800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.799000E-01 |
| Normal-vs-Stage2 |
1.226250E-01 |
| Normal-vs-Stage3 |
7.307000E-01 |
| Normal-vs-Stage4 |
8.409800E-01 |
| Stage1-vs-Stage2 |
1.733800E-01 |
| Stage1-vs-Stage3 |
3.847200E-01 |
| Stage1-vs-Stage4 |
5.616800E-01 |
| Stage2-vs-Stage3 |
7.090200E-02 |
| Stage2-vs-Stage4 |
1.378570E-01 |
| Stage3-vs-Stage4 |
9.441600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.597600E-01 |
| Normal-vs-AfricanAmerican |
9.219600E-03 |
| Normal-vs-Asian |
5.284400E-01 |
| Caucasian-vs-AfricanAmerican |
1.916210E-02 |
| Caucasian-vs-Asian |
8.937800E-01 |
| AfricanAmerican-vs-Asian |
1.491580E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.152000E-01 |
| Normal-vs-Female |
7.906400E-01 |
| Male-vs-Female |
4.794600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.146200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.804200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.707400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.559100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.966200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.962000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.109500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.124100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.456450E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.476200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.932200E-01 |
| Classical-VS-Follicular |
4.962800E-01 |
| Classical-VS-Other |
8.477000E-01 |
| Classical-VS-Normal |
4.299800E-01 |
| Tall-VS-Follicular |
6.031600E-01 |
| Tall-VS-Other |
8.335600E-01 |
| Tall-VS-Normal |
6.305800E-01 |
| Follicular-VS-Other |
9.753200E-01 |
| Follicular-VS-Normal |
9.991600E-01 |
| Other-VS-Normal |
9.797000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.932600E-01 |
| Normal-vs-N1 |
8.167800E-01 |
| N0-vs-N1 |
5.987200E-01 |
|
|
